{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:57:42Z","timestamp":1773943062558,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002739","name":"Aarhus Universitets Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00125-017-4445-6","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T03:35:01Z","timestamp":1505964901000},"page":"445-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Acute renal metabolic effect of metformin assessed with hyperpolarised MRI in rats"],"prefix":"10.1007","volume":"61","author":[{"given":"Haiyun","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte B.","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Palm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0317-2911","authenticated-orcid":false,"given":"Christoffer","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"4445_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/jdi.12328","volume":"6","author":"KY Hur","year":"2015","unstructured":"Hur KY, Lee MS (2015) New mechanisms of metformin action: focusing on mitochondria and the gut. J Diabetes Investig 6:600\u2013609","journal-title":"J Diabetes Investig"},{"key":"4445_CR2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510:542\u2013546","journal-title":"Nature"},{"key":"4445_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00125-009-1636-9","volume":"53","author":"S Vella","year":"2010","unstructured":"Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR (2010) The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia 53:809\u2013820","journal-title":"Diabetologia"},{"key":"4445_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1056\/NEJM199803263381303","volume":"338","author":"SE Inzucchi","year":"1998","unstructured":"Inzucchi SE, Maggs DG, Spollett GR et al (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338:867\u2013872","journal-title":"N Engl J Med"},{"key":"4445_CR5","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","volume":"49","author":"RS Hundal","year":"2000","unstructured":"Hundal RS, Krssak M, Dufour S et al (2000) Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49:2063\u20132069","journal-title":"Diabetes"},{"key":"4445_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S2213-8587(16)00039-5","volume":"4","author":"CS Frandsen","year":"2016","unstructured":"Frandsen CS, Dejgaard TF, Madsbad S (2016) Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus. Lancet Diabetes Endocrinol 4:766\u2013780","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4445_CR7","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1001\/jama.2015.16174","volume":"314","author":"IM Libman","year":"2015","unstructured":"Libman IM, Miller KM, DiMeglio LA et al (2015) Effect of metformin added to insulin on glycemic control among overweight\/obese adolescents with type 1 diabetes: a randomized clinical trial. JAMA 314:2241\u20132250","journal-title":"JAMA"},{"key":"4445_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/dom.12840","volume":"19","author":"JR Petrie","year":"2017","unstructured":"Petrie JR, Chaturvedi N, Ford I et al (2017) Metformin in adults with type 1 diabetes: design and methods of reducing with metformin vascular adverse lesions (REMOVAL): an international multicentre trial. Diabetes Obes Metab 19:509\u2013516","journal-title":"Diabetes Obes Metab"},{"key":"4445_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4329\/wjr.v7.i3.57","volume":"7","author":"S Capitanio","year":"2015","unstructured":"Capitanio S, Marini C, Sambuceti G, Morbelli S (2015) Metformin and cancer: technical and clinical implications for FDG-PET imaging. World J Radiol 7:57\u201360","journal-title":"World J Radiol"},{"key":"4445_CR10","first-page":"5789","volume":"35","author":"M Cazzaniga","year":"2015","unstructured":"Cazzaniga M, Bonanni B (2015) Relationship between metabolic reprogramming and mitochondrial activity in cancer cells. Understanding the anticancer effect of metformin and its clinical implications. Anticancer Res 35:5789\u20135796","journal-title":"Anticancer Res"},{"key":"4445_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/pcan.2015.35","volume":"18","author":"MJ Mayer","year":"2015","unstructured":"Mayer MJ, Klotz LH, Venkateswaran V (2015) Metformin and prostate cancer stem cells: a novel therapeutic target. Prostate Cancer Prostatic Dis 18:303\u2013309","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4445_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ctrv.2015.03.002","volume":"41","author":"L Pizzuti","year":"2015","unstructured":"Pizzuti L, Vici P, Di Lauro L et al (2015) Metformin and breast cancer: basic knowledge in clinical context. Cancer Treat Rev 41:441\u2013447","journal-title":"Cancer Treat Rev"},{"key":"4445_CR13","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","volume":"2","author":"MN Pollak","year":"2012","unstructured":"Pollak MN (2012) Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov 2:778\u2013790","journal-title":"Cancer Discov"},{"key":"4445_CR14","doi-asserted-by":"publisher","first-page":"40767","DOI":"10.18632\/oncotarget.8194","volume":"7","author":"YK Chae","year":"2016","unstructured":"Chae YK, Arya A, Malecek MK et al (2016) Repurposing metformin for cancer treatment: current clinical studies. Oncotarget 7:40767\u201340780","journal-title":"Oncotarget"},{"key":"4445_CR15","doi-asserted-by":"publisher","first-page":"c380","DOI":"10.1159\/000323739","volume":"118","author":"HJ Nye","year":"2011","unstructured":"Nye HJ, Herrington WG (2011) Metformin: the safest hypoglycaemic agent in chronic kidney disease? Nephron Clini Pract 118:c380\u2013c383","journal-title":"Nephron Clini Pract"},{"key":"4445_CR16","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1001\/jama.2014.15298","volume":"312","author":"SE Inzucchi","year":"2014","unstructured":"Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK (2014) Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 312:2668\u20132675","journal-title":"JAMA"},{"key":"4445_CR17","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.2337\/db16-0804","volume":"65","author":"AJ Lewis","year":"2016","unstructured":"Lewis AJ, Miller JJ, McCallum C et al (2016) Assessment of metformin-induced changes in cardiac and hepatic redox state using hyperpolarized [1-13C]pyruvate. Diabetes 65:3544\u20133551","journal-title":"Diabetes"},{"key":"4445_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/dmrr.2370","volume":"29","author":"C Laustsen","year":"2013","unstructured":"Laustsen C, Ostergaard JA, Lauritzen MH et al (2013) Assessment of early diabetic renal changes with hyperpolarized [1-13C]pyruvate. Diabetes Metab Res Rev 29:125\u2013129","journal-title":"Diabetes Metab Res Rev"},{"key":"4445_CR19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/mrm.26245","volume":"77","author":"C Morze von","year":"2017","unstructured":"von Morze C, Chang GY, Larson PE et al (2017) Detection of localized changes in the metabolism of hyperpolarized gluconeogenic precursors 13 C-lactate and 13 C-pyruvate in kidney and liver. Magn Reson Med 77:1429\u20131437","journal-title":"Magn Reson Med"},{"key":"4445_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ki.2013.504","volume":"86","author":"C Laustsen","year":"2014","unstructured":"Laustsen C, Lycke S, Palm F et al (2014) High altitude may alter oxygen availability and renal metabolism in diabetics as measured by hyperpolarized [1-(13)C]pyruvate magnetic resonance imaging. Kidney Int 86:67\u201374","journal-title":"Kidney Int"},{"key":"4445_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002175","volume":"94","author":"CC Kuo","year":"2015","unstructured":"Kuo CC, Yeh HC, Chen B, Tsai CW, Lin YS, Huang CC (2015) Prevalence of metformin use and the associated risk of metabolic acidosis in US diabetic adults with CKD: a national cross-sectional study. Medicine 94:e2175","journal-title":"Medicine"},{"key":"4445_CR22","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.2337\/dc13-3023","volume":"37","author":"WL Eppenga","year":"2014","unstructured":"Eppenga WL, Lalmohamed A, Geerts AF et al (2014) Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care 37:2218\u20132224","journal-title":"Diabetes Care"},{"key":"4445_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1463-1326.2006.00657.x","volume":"10","author":"S Runge","year":"2008","unstructured":"Runge S, Mayerle J, Warnke C et al (2008) Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation? Diabetes Obes Metab 10:91\u201393","journal-title":"Diabetes Obes Metab"},{"key":"4445_CR24","doi-asserted-by":"publisher","first-page":"R1443","DOI":"10.1152\/ajpregu.00502.2011","volume":"302","author":"P Persson","year":"2012","unstructured":"Persson P, Hansell P, Palm F (2012) NADPH oxidase inhibition reduces tubular sodium transport and improves kidney oxygenation in diabetes. Am J Physiol Regul Integr Comp Physiol 302:R1443\u2013R1449","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"4445_CR25","doi-asserted-by":"publisher","first-page":"F1265","DOI":"10.1152\/ajprenal.00228.2009","volume":"297","author":"L Nordquist","year":"2009","unstructured":"Nordquist L, Brown R, Fasching A, Persson P, Palm F (2009) Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption. Am J Physiol Ren Physiol 297:F1265\u2013F1272","journal-title":"Am J Physiol Ren Physiol"},{"key":"4445_CR26","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1073\/pnas.1733835100","volume":"100","author":"JH Ardenkjaer-Larsen","year":"2003","unstructured":"Ardenkjaer-Larsen JH, Fridlund B, Gram A et al (2003) Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 100:10158\u201310163","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4445_CR27","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/jmri.23753","volume":"36","author":"RE Hurd","year":"2012","unstructured":"Hurd RE, Yen YF, Chen A, Ardenkjaer-Larsen JH (2012) Hyperpolarized 13C metabolic imaging using dissolution dynamic nuclear polarization. J Magn Reson Imaging 36:1314\u20131328","journal-title":"J Magn Reson Imaging"},{"key":"4445_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fphys.2016.00072","volume":"7","author":"C Laustsen","year":"2016","unstructured":"Laustsen C (2016) Hyperpolarized renal magnetic resonance imaging: potential and pitfalls. Front Physiol 7:72","journal-title":"Front Physiol"},{"key":"4445_CR29","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/mrm.26256","volume":"77","author":"LB Bertelsen","year":"2017","unstructured":"Bertelsen LB, Nielsen PM, Qi H et al (2017) Diabetes induced renal urea transport alterations assessed with 3D hyperpolarized 13 C,15 N-urea. Magn Reson Med 77:1650\u20131655","journal-title":"Magn Reson Med"},{"key":"4445_CR30","doi-asserted-by":"publisher","first-page":"e12714","DOI":"10.14814\/phy2.12714","volume":"4","author":"H Qi","year":"2016","unstructured":"Qi H, Norlinger TS, Nielsen PM et al (2016) Early diabetic kidney maintains the corticomedullary urea and sodium gradient. Phys Rep 4:e12714. 10.14814\/phy2.12714","journal-title":"Phys Rep"},{"key":"4445_CR31","doi-asserted-by":"publisher","first-page":"F465","DOI":"10.1152\/ajprenal.00561.2015","volume":"312","author":"PM Nielsen","year":"2017","unstructured":"Nielsen PM, Laustsen C, Bertelsen LB et al (2017) In situ lactate dehydrogenase activity: a novel renal cortical imaging biomarker of tubular injury? Am J Physiol Ren Physiol 312:F465\u2013F473","journal-title":"Am J Physiol Ren Physiol"},{"key":"4445_CR32","doi-asserted-by":"publisher","first-page":"F192","DOI":"10.1152\/ajprenal.00148.2016","volume":"312","author":"C Laustsen","year":"2017","unstructured":"Laustsen C, Nielsen PM, Norlinger TS et al (2017) Antioxidant treatment attenuates lactate production in diabetic nephropathy. Am J Physiol Ren Physiol 312:F192\u2013F199","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"4445_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348 Pt","author":"MR Owen","year":"2000","unstructured":"Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348 Pt(3):607\u2013614","journal-title":"Biochem J"},{"key":"4445_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2014.07.013","volume":"20","author":"JA Baur","year":"2014","unstructured":"Baur JA, Birnbaum MJ (2014) Control of gluconeogenesis by metformin: does redox trump energy charge? Cell Metab 20:197\u2013199","journal-title":"Cell Metab"},{"key":"4445_CR35","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/cc11332","volume":"16","author":"A Protti","year":"2012","unstructured":"Protti A, Fortunato F, Monti M et al (2012) Metformin overdose, but not lactic acidosis per se, inhibits oxygen consumption in pigs. Crit Care 16:R75","journal-title":"Crit Care"},{"key":"4445_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F (2012) Cellular and molecular mechanisms of metformin: an overview. Clin Sci 122:253\u2013270","journal-title":"Clin Sci"},{"key":"4445_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1681\/ASN.2014020205","volume":"26","author":"M Dobre","year":"2015","unstructured":"Dobre M, Rahman M, Hostetter TH (2015) Current status of bicarbonate in CKD. J Am Soc Nephrol 26:515\u2013523","journal-title":"J Am Soc Nephrol"},{"key":"4445_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2337\/db10-0655","volume":"60","author":"Y Takiyama","year":"2011","unstructured":"Takiyama Y, Harumi T, Watanabe J et al (2011) Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1alpha expression and oxygen metabolism. Diabetes 60:981\u2013992","journal-title":"Diabetes"},{"key":"4445_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/ars.2007.1672","volume":"10","author":"W Ying","year":"2008","unstructured":"Ying W (2008) NAD+\/NADH and NADP+\/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10:179\u2013206","journal-title":"Antioxid Redox Signal"},{"key":"4445_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2337\/diab.44.2.234","volume":"44","author":"RG Tilton","year":"1995","unstructured":"Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Ido Y, Williamson JR (1995) Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44:234\u2013242","journal-title":"Diabetes"},{"key":"4445_CR41","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/mrm.25692","volume":"74","author":"C Laustsen","year":"2015","unstructured":"Laustsen C, Hansen ES, Kjaergaard U, Bertelsen LB, Ringgaard S, Stodkilde-Jorgensen H (2015) Acute porcine renal metabolic effect of endogastric soft drink administration assessed with hyperpolarized [1-(13)C]pyruvate. Magn Reson Med 74:558\u2013563","journal-title":"Magn Reson Med"},{"key":"4445_CR42","doi-asserted-by":"crossref","unstructured":"Hansen ESS, Tougaard RS, Norlinger TS et al (2017) Imaging porcine cardiac substrate selection modulations by glucose, insulin and potassium intervention: a hyperpolarized [1-13C]pyruvate study. NMR Biomed 30:e3702","DOI":"10.1002\/nbm.3702"},{"key":"4445_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/nbm.1573","volume":"24","author":"HJ Atherton","year":"2011","unstructured":"Atherton HJ, Schroeder MA, Dodd MS et al (2011) Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS. NMR Biomed 24:201\u2013208","journal-title":"NMR Biomed"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4445-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4445-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4445-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T03:53:05Z","timestamp":1719460385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4445-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4445"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4445-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]}}}